Temporary stent placement with concurrent chemoradiation therapy in patients with unresectable oesophageal carcinoma: is there an optimal time for stent removal?
- 21 February 2013
- journal article
- Published by Springer Nature in European Radiology
- Vol. 23 (7) , 1940-1945
Abstract
To investigate the influence of the timing of stent removal on the outcome of temporary stent placement with concurrent chemoradiation therapy in patients with unresectable oesophageal carcinoma. Retrospective analysis was performed on 52 patients undergoing temporary stent placement. Stents were electively removed within 4 weeks in 15 patients (group A), 4–6 weeks in 17 patients (group B) and after 6 weeks in 20 patients (group C). Recurrent symptoms after stent removal, dysphagia score and overall survival periods were compared among the groups. Stent placement and removal were technically successful in all patients. The dysphagia score was significantly improved in all groups (P < 0.001). In 19 patients (36 %), recurrent symptoms occurred 15–441 days after stent removal. In group A, recurrent obstruction was significantly higher than in groups B (P = 0.049) and C (P = 0.019). Incidence of oesophago-respiratory fistulas in group C was significantly higher than in group A (P = 0.027). There was no significant difference in survival periods. The ideal time for stent removal likely falls between 4 and 6 weeks following the start of palliative CCRT allowing the temporary stents to relieve dysphagia effectively in patients with unresectable oesophageal carcinoma. • Stents are usually required for unresectable oesophageal carcinoma • Optimal timing of stent removal is 4–6 weeks after starting palliative CCRT. • Early stent removal ( • Delayed stent removal (>6 weeks) is associated with greater oesophago-respiratory fistula development.Keywords
This publication has 14 references indexed in Scilit:
- The use of self-expandable metallic stents for palliative treatment of inoperable esophageal cancerDiseases of the Esophagus, 2010
- Temporary Placement of Self-Expanding Oesophageal Stents as Bridging for Neo-Adjuvant TherapyAnnals of Surgical Oncology, 2009
- Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapyGastrointestinal Endoscopy, 2009
- Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysisDiseases of the Esophagus, 2009
- Palliative therapyJournal of Surgical Oncology, 2005
- Comparison of Temporary and Permanent Stent Placement with Concurrent Radiation Therapy in Patients with Esophageal CarcinomaJournal of Vascular and Interventional Radiology, 2005
- Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinomaEuropean Journal of Gastroenterology & Hepatology, 2004
- Covered Retrievable Expandable Nitinol Stents in Patients with Benign Esophageal Strictures: Initial ExperienceRadiology, 2000
- A new design metal stent (Flamingo stent) for palliation of malignant dysphagia: a prospective studyGastrointestinal Endoscopy, 2000
- The effect of radiotherapy on dysphagia and survival in patients with esophageal cancerRadiotherapy and Oncology, 1988